Monoclonal Antibody Companies Command Premiums
Five Key Factors Weighing on Dendreon
Cancer Immunotherapy to Take Center Stage at ASCO
Cyclin-dependent Cancer Confab Preview
Monoclonal antibodies, which have been approved for immunological, anti-infective, ophthalmic, cancer and other categories,...
Shares of Dendreon Corporation (DNDN) have declined significantly from an all-time high of $57.67...
In early April 2010, we published a 150-page industry report titled “Cancer Vaccine Therapies:...
For more than a century, the American Association of Cancer Research has held...
Monoclonal antibodies, which have been approved for immunological, anti-infective, ophthalmic, cancer and other categories, represent one of the most successful therapeutic drug classes. Ten monoclonal antibodies have been approved for cancer therapy alone, including three blockbuster products sold by the Roche Group (RHHBY) – Avastin® , Rituxan® , and Herceptin® that collectively represented...
Read More »
Shares of Dendreon Corporation (DNDN) have declined significantly from an all-time high of $57.67 in late April 2010 when the company received U.S. Food and Drug Administration approval for Provenge® , the first active immunotherapy approved for the treatment of cancer in the U.S. Today, shares of Dendreon traded as low as $28.01,...
Read More »
The life sciences industry plays a critical role in the United States economy. Innovative new medicines developed by life sciences companies provide better patient outcomes, improved quality of care, increased life expectancy, and lead to economic gains. Currently, the strengths [e.g. innovation, quality of...
Read More »
On February 17, 2009, President Obama announced as part of the 2009 stimulus bill, an increase of approximately $10B dollars to the budget for the National Institute of Health (NIH). This is a much needed increase in funding as government sponsored biomedical research has remained relatively flat over the past several years (Figure 1)....
Read More »
Subscribe to RSS
Subscribe to email
Life Science Digest is published by MD Becker Partners LLC, a boutique management and strategy consulting firm focusing on both public and private companies in the life sciences industry, including pharmaceuticals, biotechnology, and medical devices. For more information, please visit the firm's website at: www.mdbpartners.com
Heterotrimeric G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors (1) and play a critical role in transmitting signals from outside to inside a cell. GPCRs role in cell physiology and pathophysiology is well documented as nearly all physiological functions are dependent on GCPR signaling (1,2). The activation of a GPCR...
